Biobanking biological materials and linkage to clinical information

Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands
Biobanking biological materials and linkage to clinical information ( Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands )
6 Jan 2015

2nd EurocanPlatform translational research course is good for networking

Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
2nd EurocanPlatform translational research course is good for networking ( Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal )
6 Jan 2015

Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

The DNA damage response and cancer therapy

Dr Christopher Lord, The Institute of Cancer Research, London, UK
The DNA damage response and cancer therapy ( Dr Christopher Lord, The Institute of Cancer Research, London, UK )
6 Jan 2015

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium
New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )
6 Jan 2015

New drug, ASP8273, shows response in Japanese patients with treatment-resistant non-small cell lung cancer

Dr Haruyasu Murakami - Shizuoka Cancer Center, Shizuoka, Japan
New drug, ASP8273, shows response in Japanese patients with treatment-resistant non-small cell lung cancer ( Dr Haruyasu Murakami - Shizuoka Cancer Center, Shizuoka, Japan )
27 Nov 2014

Early events found to trigger lung cancer twenty years before diagnosis

Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK
Early events found to trigger lung cancer twenty years before diagnosis ( Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK )
14 Nov 2014

Thoracic radiotherapy in extensive stage small cell lung cancer improved survival

Dr Corinne Faivre-Finn - The Christie, Manchester, UK
Thoracic radiotherapy in extensive stage small cell lung cancer improved survival ( Dr Corinne Faivre-Finn - The Christie, Manchester, UK )
11 Nov 2014

Multidisciplinary approach to oncology improves accuracy of lung cancer screening

Prof Peter Kuhn - University of Southern California, Los Angeles, USA
Multidisciplinary approach to oncology improves accuracy of lung cancer screening ( Prof Peter Kuhn - University of Southern California, Los Angeles, USA )
10 Nov 2014